Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-8-16
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1097-6787
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e70-2
pubmed:meshHeading
pubmed-meshheading:20708466-Antigens, CD30, pubmed-meshheading:20708466-Biological Markers, pubmed-meshheading:20708466-Chemokine CCL17, pubmed-meshheading:20708466-Cyclosporine, pubmed-meshheading:20708466-Dermatitis, Atopic, pubmed-meshheading:20708466-Dose-Response Relationship, Drug, pubmed-meshheading:20708466-Drug Administration Schedule, pubmed-meshheading:20708466-Female, pubmed-meshheading:20708466-Humans, pubmed-meshheading:20708466-Male, pubmed-meshheading:20708466-Mycophenolic Acid, pubmed-meshheading:20708466-Observer Variation, pubmed-meshheading:20708466-Pilot Projects, pubmed-meshheading:20708466-Prognosis, pubmed-meshheading:20708466-Sensitivity and Specificity, pubmed-meshheading:20708466-Severity of Illness Index, pubmed-meshheading:20708466-Single-Blind Method, pubmed-meshheading:20708466-Tablets, Enteric-Coated, pubmed-meshheading:20708466-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
pubmed:publicationType
Letter, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't